Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
Çã¼ÁƾÁÖ - »õâ
|
F.Hoffmann-La Roche |
E01840531 | Trastuzumab | Àü¹®ÀǾàǰ | »èÁ¦ | ºÐ¾÷¿¹¿ÜÀǾàǰ |
|
Çã¼ÁƾÁÖ150mg - »õâ
|
F.Hoffmann-La Roche |
E01840761 | Trastuzumab | Àü¹®ÀǾàǰ | ±Þ¿© |
| trastuzumab |
A type of monoclonal antibody used in cancer detection or therapy. Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. Trastuzumab blocks the effects of the growth factor protein HER2, which transmits growth signals to breast cancer cells.
Ãâó: www.stjude.org/glossary
|
|---|---|
| trastuzumab |
A humanized anti-ErbB2 monoclonal antibody approved for treating patients whose breast cancers overexpress ErbB2 protein or demonstrate ErbB2 gene amplification, it is currently being tested in combination with other therapies.
Ãâó: www.jco.org/cgi/glossarylookup
|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|